InvestSMART

pSivida Corp (ASX: PVA) - Announcements

DELISTED - Current share price for PVA : $2.990

ASX company news and announcements for pSivida Corp (PVA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All pSivida Corp (PVA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than pSivida Corp (PVA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for pSivida Corp (PVA)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Appendix 3B 5 May 2016 8:27AM $3.910 $2.990 fallen by 23.53%
- pSivida CEO to present at 2016 International Symposium 5 May 2016 8:26AM $3.910 $2.990 fallen by 23.53%
- Medidur for uveitis granted orphan drug designation in Europ 3 May 2016 8:25AM $3.900 $2.990 fallen by 23.33%
- pSivida announces date and time of 3Q 2016 financial results 28 Apr 2016 8:25AM $4.100 $2.990 fallen by 27.07%
- Appendix 3B 6 Apr 2016 8:19AM $3.750 $2.990 fallen by 20.27%
- pSivida to present at Sidoti Spring 2016 Emerging Growth Con 29 Mar 2016 8:19AM $3.500 $2.990 fallen by 14.57%
- pSivida CEO Acquires Shares 23 Mar 2016 8:25AM $3.500 $2.990 fallen by 14.57%
- Additional Favorable 6-month safety results for Medidur 16 Mar 2016 8:16AM $3.850 $2.990 fallen by 22.34%
- Appendix 3B 2 Mar 2016 8:23AM $3.940 $2.990 fallen by 24.11%
- Final Director's Interest Notice 11 Feb 2016 8:27AM $4.700 $2.990 fallen by 36.38%
- Corporate Governance Report 10 Feb 2016 9:56AM $4.700 $2.990 fallen by 36.38%
- Half Yearly Report and Accounts 10 Feb 2016 8:26AM $4.700 $2.990 fallen by 36.38%
- Director Appointment/Resignation 9 Feb 2016 2:03PM $4.700 $2.990 fallen by 36.38%
- pSivida Corp. Provides Co Update and Reports Q2 FY 2016 resu 9 Feb 2016 8:21AM $4.830 $2.990 fallen by 38.10%
- pSivida announces 2Q FY 16 Financial Results release date 2 Feb 2016 8:27AM $5.100 $2.990 fallen by 41.37%
- Appendix 3B 2 Feb 2016 8:27AM $5.100 $2.990 fallen by 41.37%
- pSivida CEO to present at 18th Annual Bio CEO & Investor Con 29 Jan 2016 8:21AM $5.100 $2.990 fallen by 41.37%
- pSivida Closes $17.8 Million Offering 14 Jan 2016 8:26AM $5.500 $2.990 fallen by 45.64%
- 8K document filed with US SEC 11 Jan 2016 8:28AM $6.000 $2.990 fallen by 50.17%
- prospectus supplement as filed with US SEC 11 Jan 2016 8:26AM $6.000 $2.990 fallen by 50.17%
- pSivida announces pricing of $16 Million public offering of 8 Jan 2016 9:30AM $5.740 $2.990 fallen by 47.91%
- Trading Halt 7 Jan 2016 10:52AM $5.740 $2.990 fallen by 47.91%
- pSivida Announces Proposed Public Offering of Common Stock 7 Jan 2016 10:08AM $6.650 $2.990 fallen by 55.04%
- SEC Form 4 Change in Insider holdings 6 Jan 2016 10:10AM $6.650 $2.990 fallen by 55.04%
- Appendix 3B 5 Jan 2016 8:27AM $6.650 $2.990 fallen by 55.04%

151 - 175 of 360 results

Page 7 of 15

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.